A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma

Authors: Christina L. Roland, Elise F. Nassif Haddad, Emily Z. Keung, Wei-Lien Wang, Alexander J. Lazar, Heather Lin, Manoj Chelvanambi, Edwin R. Parra, Khalida Wani, B. Ashleigh Guadagnolo, Andrew J. Bishop, Elizabeth M. Burton, Kelly K. Hunt, Keila E. Torres, Barry W. Feig, Christopher P. Scally, Valerae O. Lewis, Justin E. Bird, Ravin Ratan, Dejka Araujo, M. Alexandra Zarzour, Shreyaskumar Patel, Robert Benjamin, Anthony P. Conley, J. Andrew Livingston, Vinod Ravi, Hussein A. Tawbi, Patrick P. Lin, Bryan S. Moon, Robert L. Satcher, Bilal Mujtaba, Russell G. Witt, Raymond S. Traweek, Brandon Cope, Rossana Lazcano, Chia-Chin Wu, Xiao Zhou, Mohammad M. Mohammad, Randy A. Chu, Jianhua Zhang, Ashish Damania, Pranoti Sahasrabhojane, Taylor Tate, Kate Callahan, Sa Nguyen, Davis Ingram, Rohini Morey, Shadarra Crosby, Grace Mathew, Sheila Duncan, Cibelle F. Lima, Jean-Yves Blay, Wolf Herman Fridman, Kenna Shaw, Ignacio Wistuba, Andrew Futreal, Nadim Ajami, Jennifer A. Wargo, Neeta Somaiah

Published: 2024-02-13

DOI: 10.1038/s43018-024-00726-z

Source: Full article


Abstract

No abstract found.